ATF6 and graft versus host disease: Further research is necessary to comprehend the influence of PERK and ATF6 signaling on disease progression and to investigate strategies for regulating the interplay of the three UPR mediators, aiming to prevent GVHD while maintaining GVL activity in allo-HCT.